🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

9 recruiting trials

for Myelomeningocele

Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele NCT03856034NA2 sites📍 Los Angeles📍 Wellington USFetus · Tests: Fetoscopy tSCS in Children With Spina Bifida NCT07615686NA1 site📍 Pittsburgh Bailey Petersen · Tests: Transcutaneous stimulator Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial NCT04652908Phase 1, Phase 21 site📍 Sacramento University of California, Davis · Tests: Placental Mesenchymal Stem Cells seeded on a commercially available dural graft extracellular matrix, Untreated contemp… Cryopreserved Human Umbilical Cord as a Meningeal Patch in Fetoscopic Spina Bifida Repair NCT06042140NA1 site📍 Houston The University of Texas Health Science Center, Houston · Tests: NEOX Cord 1K applied fetoscopically Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects NCT06929572NA1 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Autologous umbilical cord patch Safety and Efficacy of Devices Used in Fetoscopic Neural Tube Defect Repair Cases NCT05672849NA1 site📍 Houston Michael A Belfort · Tests: Modified Surgical Instruments/Devices (Sheaths and Irrigator) Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida NCT06918119NA1 site📍 Rochester Mayo Clinic · Tests: Transcutaneous stimulation In Utero Surgery for Fetal Myelomeningocele: Decision-making Mechanisms and Psychological Impact of Prenatal Therapy NCT06796972NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Semi-structured interviews with a psychologist Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC NCT05491525Phase 2, Phase 338 sites📍 Little Rock📍 Orange📍 Aurora Urovant Sciences GmbH · Tests: Vibegron
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy